Literature DB >> 27431598

Does Postoperative Cardiac Troponin-I Have Any Prognostic Value in Predicting Midterm Mortality After Congenital Cardiac Surgery?

Mona Momeni1, Alain Poncelet2, Jean Rubay2, Amine Matta3, Laurent Veevaete3, Thierry Detaille4, Laurent Houtekie4, Stéphan Clement de Clety4, Emilien Derycke4, Stéphane Moniotte5, Thierry Sluysmans5, Francis Veyckemans3.   

Abstract

OBJECTIVES: This study evaluated the prognostic value of postoperative cardiac troponin-I (cTnI) in predicting all-cause mortality up to 3 months after normothermic congenital cardiac surgery.
DESIGN: Prospective observational study.
SETTING: University hospital. PARTICIPANTS: All children ages 0 to 10 years.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: cTnI was measured after the induction of anesthesia but before the surgery, at the pediatric intensive care unit arrival, and at 4, 12, and 24 hours postoperatively. Follow-up was extended up to 6 months. Overall, 169 children were analyzed, of whom 165 were survivors and 4 were nonsurvivors. cTnI levels were significantly higher in nonsurvivors only at 24 hours (p = 0.047). Children undergoing surgery with cardiopulmonary bypass (CPB) had significantly higher cTnI concentrations compared with those without CPB (p<0.001). Logistic regression analysis was performed on the 146 children in the CPB group with the following predictive variables: CPB time, postoperative cTnI concentrations, the presence of a cyanotic malformation, and intramyocardial incision. None of the variables predicted mortality. Postoperative cTnI concentrations did not predict 6 months׳ mortality. Only cTnI at 24 hours predicted the length of stay in the pediatric intensive care unit.
CONCLUSIONS: This study did not find that postoperative cTnI concentration predicted midterm mortality after normothermic congenital heart surgery. (ClinicalTrials.gov identifier: NCT01616394).
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiac troponin-I; cardiopulmonary bypass; congenital heart surgery; mortality

Mesh:

Substances:

Year:  2016        PMID: 27431598     DOI: 10.1053/j.jvca.2016.02.018

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  2 in total

1.  MiRNA-208a as a Sensitive Early Biomarker for the Postoperative Course Following Congenital Heart Defect Surgery.

Authors:  Keren Zloto; Tal Tirosh-Wagner; Yoav Bolkier; Omer Bar-Yosef; Amir Vardi; David Mishali; Yael Nevo-Caspi; Gidi Paret
Journal:  Pediatr Cardiol       Date:  2018-06-12       Impact factor: 1.655

2.  Comparison of prognostic ability of perioperative myocardial biomarkers in acute type A aortic dissection.

Authors:  Ming Gong; Zining Wu; Xinliang Guan; Wenjian Jiang; Hongjia Zhang
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.